Levilactobacillus brevis KU15147 Attenuates MIA-Induced Osteoarthritis by Modulating Inflammatory Responses and Cartilage Metabolism
Journal of Microbiology and Biotechnology · 13.05.2026 · 36
DOI: 10.4014/jmb.2603.03042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, online erschienen am 13.05.2026. Verfasst von Na-Kyoung Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Biotechnology of Animal Resources, Konkuk University, Seoul 05029, Republic of Korea. Hauptthemen laut MEDLINE: Osteoarthritis, Inflammation, Cartilage. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This study investigated the protective effects of Levilactobacillus brevis KU15147 on monosodium iodoacetate (MIA)-induced osteoarthritis in rats and inflammatory chondrocyte models. After 10 days of oral administration, osteoarthritis was induced via two intra-articular injections of MIA (50 μl of 60 mg/mL) at 3-day intervals. Experimental groups included normal control (NC), MIA-treated control (C), a positive control treated with indomethacin (PC, 3 mg/kg body weight/day), L. brevis KU15147 low-dose (15147-L, 1 × 108 CFU/rat/day), and L. brevis KU15147 high-dose (15147-H, 1 × 109 CFU/rat/day) groups. Knee thickness measurements, micro-computed tomography, and histological analyses were performed to evaluate joint structural changes. Serum levels of PGE2, LTB4, 5-lipoxgenase, tumor necrosis factor-α, interleukin (IL)-6, and IL-1β were measured, and cartilage metabolism- and inflammation-related gene expression were analyzed via quantitative real-time PCR. Furthermore, H2O2- or lipopolysaccharide (LPS)-stimulated chondrocytes were used to assess cytoprotective and anti-inflammatory effects ex vivo. MIA administration–induced cartilage degeneration, joint swelling, inflammatory mediator elevation, as well as catabolic and pro-inflammatory gene expression upregulation. L. brevis KU15147 treatment attenuated structural damage, suppressed systemic and local inflammatory responses, and restored the balance between anabolic and catabolic gene expression in both in vivo and ex vivo models. These findings suggest that L. brevis KU15147 exerts protective effects against osteoarthritis progression through the modulation of inflammatory pathways and cartilage metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Science and Biotechnology of Animal Resources, Konkuk University, Seoul 05029, Republic of Korea.
- Department of Food and Nutrition, Kyungnam University, Changwon 51767, Republic of Korea.
- View of Creativity, GHBio Co., Ltd., 120 Neungdong-Ro, Konkuk University, Seoul 05029, Republic of Korea.
Zitieren
APA
Lee, N. K., Lee, Y., Choi, M., Park, E., & Paik, H. D. (2026). Levilactobacillus brevis KU15147 Attenuates MIA-Induced Osteoarthritis by Modulating Inflammatory Responses and Cartilage Metabolism. Journal of Microbiology and Biotechnology, 36. https://doi.org/10.4014/jmb.2603.03042
Vancouver
Lee NK, Lee Y, Choi M, Park E, Paik HD. Levilactobacillus brevis KU15147 Attenuates MIA-Induced Osteoarthritis by Modulating Inflammatory Responses and Cartilage Metabolism. Journal of Microbiology and Biotechnology. 2026;36. doi:10.4014/jmb.2603.03042
BibTeX
@article{Lee2026,
author = {Lee, Na-Kyoung and Lee, Yunjung and Choi, Mijoo and Park, Eunju and Paik, Hyun-Dong},
title = {Levilactobacillus brevis KU15147 Attenuates MIA-Induced Osteoarthritis by Modulating Inflammatory Responses and Cartilage Metabolism},
journal = {Journal of Microbiology and Biotechnology},
year = {2026},
volume = {36},
doi = {10.4014/jmb.2603.03042}
}
EUVIMED